Showing results (21-30 of 231) with videos related to
Sort By:
Pageof 24
International Journal of Cancer|December 4, 2003
Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cellsYuhong Lu, Xiaolin Zi, Michael PollakCancer Prevention Research (Philadelphia, Pa.)|April 3, 2012
Metformin and hepatic carcinogenesisMichael Pollak, Ana M Gonzalez-AnguloMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 28, 2002
Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cellsAnne Camirand, Yuhong Lu, Michael PollakBiochimica Et Biophysica Acta. Molecular Cell Research|May 14, 2021
The role of GSK3 in metabolic pathway perturbations in cancerDavid Papadopoli, Michael Pollak, Ivan TopisirovicGrowth Factors (Chur, Switzerland)|April 8, 2010
IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcriptionMatei Mireuta, Andrew Darnel, Michael PollakThe Journal of Biological Chemistry|March 11, 2011
Binding between insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 is not influenced by glucose or 2-deoxy-D-glucoseMatei Mireuta, Mark A Hancock, Michael PollakJAMA Oncology|July 17, 2015
5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate CancerLaurent Azoulay, Maria Eberg, Serge Benayoun, et al.Biochemical and Biophysical Research Communications|December 31, 2003
Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cellsYuhong Lu, Xiaolin Zi, Yunhua Zhao, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 4, 2009
Current status and challenges associated with targeting mTOR for cancer therapyRyan J O Dowling, Michael Pollak, Nahum SonenbergBiochemical and Biophysical Research Communications|September 13, 2005
PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2Randy J Levitt, Maria-Magdalena Georgescu, Michael PollakPageof 24